Back to results
US 5,856,128 AGranted
Human nucleic acid binding protein
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Janice Au-Young, Phillip R. Hawkins, Jennifer L. Hillman
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeIncyte Pharmaceuticals, Inc.
InventorsOlga Bandman, Janice Au-Young, Phillip R. Hawkins, Jennifer L. Hillman
Estimating the term…
The present invention provides polynucleotides which identify and encode a novel human nucleic acid binding protein (NABP). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding NABP. The invention also provides for the use of substantially purified NABP or its antagonists, in pharmaceutical compositions for the treatment of diseases associated with the expression of NABP. Additionally, the invention provides for the use of antisense molecules to NABP in pharmaceutical compositions for treatment of diseases associated with the expression of NABP. The invention also describes diagnostic assays which utilize diagnostic compositions comprising the polynucleotide, fragments or the complement thereof, which hybridize with the genomic sequence or the transcript of polynucleotides encoding NABP or anti-NABP antibodies which specifically bind to NABP.
An isolated and purified polynucleotide sequence encoding the protein having the amino acid sequence of SEQ ID NO:
An isolated and purified polynucleotide sequence which is the complement SEQ ID NO:2.
Dependencies are inferred from the claim text.